Literature DB >> 9835856

Aminoglycosides: a practical review.

L S Gonzalez1, J P Spencer.   

Abstract

Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms. Gentamicin is the most commonly used aminoglycoside, but amikacin may be particularly effective against resistant organisms. Aminoglycosides are used in the treatment of severe infections of the abdomen and urinary tract, as well as bacteremia and endocarditis. They are also used for prophylaxis, especially against endocarditis. Resistance is rare but increasing in frequency. Avoiding prolonged use, volume depletion and concomitant administration of other potentially nephrotoxic agents decreases the risk of toxicity. Single daily dosing of aminoglycosides is possible because of their rapid concentration-dependent killing and post-antibiotic effect and has the potential for decreased toxicity. Single daily dosing of aminoglycosides appears to be safe, efficacious and cost effective. In certain clinical situations, such as patients with endocarditis or pediatric patients, traditional multiple dosing is still usually recommended.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835856

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  41 in total

1.  Aminoglycoside-induced Hearing Loss Among Patients Being Treated for Drug-resistant Tuberculosis in South Africa: A Prediction Model.

Authors:  Hyejeong Hong; David W Dowdy; Kelly E Dooley; Howard W Francis; Chakra Budhathoki; Hae-Ra Han; Jason E Farley
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.

Authors:  Hyejeong Hong; Kelly E Dooley; Laura E Starbird; Howard W Francis; Jason E Farley
Journal:  Arch Toxicol       Date:  2019-04-08       Impact factor: 5.153

3.  The spatial profiles and metabolic capabilities of microbial populations impact the growth of antibiotic-resistant mutants.

Authors:  Karishma S Kaushik; Nalin Ratnayeke; Parag Katira; Vernita D Gordon
Journal:  J R Soc Interface       Date:  2015-06-06       Impact factor: 4.118

4.  Pathogens and antibiotic sensitivities in endophthalmitis.

Authors:  Geraldine R Slean; Neal H Shorstein; Liyan Liu; John F Paschal; Kevin L Winthrop; Lisa J Herrinton
Journal:  Clin Exp Ophthalmol       Date:  2017-01-31       Impact factor: 4.207

5.  Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.

Authors:  H Hong; D W Dowdy; K E Dooley; H W Francis; C Budhathoki; H-R Han; J E Farley
Journal:  Int J Tuberc Lung Dis       Date:  2020-01-01       Impact factor: 2.373

6.  Simultaneous delivery of antibiotics neomycin and ampicillin in drinking water inhibits fermentation of resistant starch in rats.

Authors:  Diana G Carvajal-Aldaz; Justin L Guice; Ryan C Page; Anne M Raggio; Roy J Martin; Claudia Husseneder; Holiday A Durham; James Geaghan; Marlene Janes; Ted Gauthier; Diana Coulon; Michael J Keenan
Journal:  Mol Nutr Food Res       Date:  2016-12-22       Impact factor: 5.914

7.  Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses.

Authors:  Mehdi El Hassani; Jean-Alexandre Caissy; Amélie Marsot
Journal:  Clin Pharmacokinet       Date:  2021-01-15       Impact factor: 6.447

8.  Aminoglycoside dosages and nephrotoxicity: quantitative relationships.

Authors:  Florent Rougier; Michel Ducher; Michel Maurin; Stéphane Corvaisier; Daniel Claude; Roger Jelliffe; Pascal Maire
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 9.  A Surgeon's Guide to the Various Antibiotic Dips Available During Penile Prosthesis Implantation.

Authors:  Soum D Lokeshwar; Joshua Bitran; Vinayak Madhusoodanan; Bruce Kava; Ranjith Ramasamy
Journal:  Curr Urol Rep       Date:  2019-01-30       Impact factor: 3.092

10.  Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.

Authors:  Andres F Zuluaga; Maria Agudelo; John J Cardeño; Carlos A Rodriguez; Omar Vesga
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.